[HTML][HTML] Bibliometric study of sodium glucose cotransporter 2 inhibitors in cardiovascular research
L Chen, S Ma, D Hu, H Lin, Y Zhu, K Chen… - Frontiers in …, 2020 - frontiersin.org
Background An increasing number of studies have shown that sodium glucose cotransporter
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
[引用][C] Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
L Chen, S Ma, D Hu, H Lin, Y Zhu, K Chen… - Frontiers in …, 2020 - jglobal.jst.go.jp
Adingupu DD Göpel SO Grönros J. Behrendt M. Sotak M. Miliotis T..(2019). SGLT2 inhibition
with empagliflozin improves coronary microvascular function and cardiac contractility in …
with empagliflozin improves coronary microvascular function and cardiac contractility in …
Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research.
L Chen, S Ma, D Hu, H Lin, Y Zhu, K Chen… - Frontiers in …, 2020 - europepmc.org
Background An increasing number of studies have shown that sodium glucose cotransporter
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
[HTML][HTML] Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
L Chen, S Ma, D Hu, H Lin, Y Zhu, K Chen… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Background An increasing number of studies have shown that sodium glucose cotransporter
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
L Chen, S Ma, D Hu, H Lin, Y Zhu… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Background An increasing number of studies have shown that sodium glucose cotransporter
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
L Chen, S Ma, D Hu, H Lin, Y Zhu, K Chen… - … Protection and Heart …, 2022 - books.google.com
Background: An increasing number of studies have shown that sodium glucose
cotransporter 2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular …
cotransporter 2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular …
[PDF][PDF] Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
L Chen, S Ma, D Hu, H Lin, Y Zhu, K Chen… - Front. Pharmacol. 11 …, 2020 - researchgate.net
Background: An increasing number of studies have shown that sodium glucose
cotransporter 2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular …
cotransporter 2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular …
[引用][C] Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
L Chen, S Ma, D Hu, H Lin, Y Zhu, K Chen… - Frontiers in …, 2020 - hero.epa.gov
Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research |
Health & Environmental Research Online (HERO) | US EPA Jump to main content US EPA …
Health & Environmental Research Online (HERO) | US EPA Jump to main content US EPA …
Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research.
L Chen, S Ma, D Hu, H Lin, Y Zhu, K Chen… - Frontiers in …, 2020 - europepmc.org
Background An increasing number of studies have shown that sodium glucose cotransporter
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …
2 (SGLT2) inhibitors, initially used as antidiabetic agents, have cardiovascular (CV) benefits …